ketoconazole and 1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol

ketoconazole has been researched along with 1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charman, WN; Edwards, GA; Khoo, SM; Porter, JH	1

Trials

1 trial(s) available for ketoconazole and 1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol

Article	Year
Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole. Journal of pharmaceutical sciences, 1998, Volume: 87, Issue:12 Topics: Administration, Oral; Animals; Antimalarials; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dogs; Drug Interactions; Ketoconazole; Male; Mixed Function Oxygenases; Phenanthrenes	1998

Article

Year

Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole.

Journal of pharmaceutical sciences, 1998, Volume: 87, Issue:12

Topics: Administration, Oral; Animals; Antimalarials; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dogs; Drug Interactions; Ketoconazole; Male; Mixed Function Oxygenases; Phenanthrenes

1998